| Parameters | Absolute frequencies (n) | Relatives frequencies (%) |
| Child’s vaccination location |
|
|
| Health post | 368 | 56.0 |
| Village (advanced strategy) | 199 | 30.3 |
| Health center | 84 | 12.8 |
| Hospital | 5 | 0.8 |
| Private clinic | 1 | 0.1 |
| Distance between home and place of vaccination |
| |
| Less than 100m | 288 | 43.9 |
| At least100m | 369 | 56.1 |
| Profile of the vaccinator |
|
|
| Doctor, nurse or midwife | 300 | 45.7 |
| Community worker | 357 | 54.3 |
| Systematic delivery of information by the vaccinator |
| |
| Date of next contact | 571 | 86.9 |
| Adverse effects of the vaccine administered | 539 | 82.0 |
| Vaccine-protected diseases | 440 | 67.0 |
| Availability of vaccination record |
|
|
| Yes | 606 | 92.2 |
| No | 51 | 7.8 |
| Vaccines received |
|
|
| BCG | 606 | 92.2 |
| OPV 1 | 622 | 94.7 |
| OPV 2 | 577 | 87.8 |
| OPV 3 | 552 | 85.4 |
| Penta 1 | 577 | 87.8 |
| Penta 2 | 552 | 85.4 |
| Penta 3 | 560 | 85.2 |
| Antipneumococcic 1 (Pneumo 1) | 610 | 92.8 |
| Antipneumococcic 2 (Pneumo 2) | 585 | 89.0 |
| Antipneumococcic 3 (Pneumo 3) | 552 | 85.4 |
| Yellow fever (YF) | 390 | 59.4 |
| Measle-rubeola 1 (MR1) | 388 | 59.1 |
| Differences between antigens of same contact |
| |
| Penta1/OPV1 | 45 | 7.23 |
| Penta2/OPV2 | 25 | 4.33 |
| Penta3/OPV3 | 8 | 1.42 |
| Penta1/Pneumo1 | 33 | 5.40 |